Detection of Australian bat lyssavirus using a fluorogenic probe

Background: Australian bat lyssavirus (ABLV) has been transmitted to humans following a scratch or bite from an infected bat in two cases. Following a scratch or bite to a person, the bat is usually submitted for testing and diagnosis is made using a direct fluorescent antibody test on a brain smear. A nested RT-PCR assay has also been utilised to confirm diagnosis. If positive for lyssavirus, post-exposure prophylaxis is administered. Objectives: The TaqMan(TM) assay was developed to improve the diagnosis of ABLV infection, following problems encountered with the generation of spurious PCR products in the nested RT-PCR and also to reduce the high risk of contamination inherent with nested PCRs. Study design: RNA was extracted from 161 bat brains and the samples were compared using a conventional RTPCR and the TaqMan based assay. Samples from a patient with an ABLV infection collected antemortem and postmortem were also tested. Results: The sensitivity of the new TaqMan based PCR assay compared favourably with the nested PCR previously in use in our laboratory. This assay was able to detect RNA in samples collected antemortem and postmortem for the diagnosis of a human case of ABLV. Conclusions: The major advantage of the TaqMan(TM) based assay was the speed of diagnosis with a result within minutes of completing the PCR (a result within 4 It. of receiving the specimen). This test greatly reduces the chance of false positives through the elimination of second-round PCR and the requirement for agarose gels. The assay is sensitive and specific and should be invaluable for future antemortem and postmortem diagnosis of ABLV infection in humans. Crown Copyright (C) 2002 Published by Elsevier Science B.V. All rights reserved.